CABALETTA BIO, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-167.9M | $-115.9M | $-67.7M | $-53.0M | $-46.3M | $-33.3M | $-16.9M | $-12.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $1.6M | $1.7M | $1.4M | $1.2M | $733.0K | $354.0K | $104.0K | $0 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $20.9M | $19.5M | $11.3M | $6.9M | $5.8M | $4.4M | $2.3M | $606.0K |
| Net Cash from Operating Activities | $-131.1M | $-88.2M | $-53.5M | $-46.4M | $-34.1M | $-26.8M | $-16.0M | $-4.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.2M | $2.2M | $687.0K | $2.5M | $1.2M | $635.0K | $693.0K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-50.3M | $47.3M | $-22.5M | $-27.2M | $6.0M | $-8.0M | $-693.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $100.3M | $11.7M | $187.6M | $33.0M | $48.9M | $-24.0K | $119.9M | $37.7M |
| Net Change in Cash | $-81.0M | $-29.3M | $111.6M | — | — | — | — | — |
| Free Cash Flow | $-132.3M | $-90.4M | $-54.2M | $-48.8M | $-35.3M | $-27.4M | $-16.7M | — |